CTT Pharmaceutical Holdings, Inc. (CTTH)
0.055
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
CTT Pharmaceutical Holdings Enterprise Value : 3.304M for Oct. 22, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 3.304M |
| October 21, 2026 | 3.400M |
| October 20, 2026 | 3.537M |
| October 19, 2026 | 3.537M |
| October 16, 2026 | 3.537M |
| October 15, 2026 | 3.543M |
| October 14, 2026 | 3.543M |
| October 13, 2026 | 3.543M |
| October 12, 2026 | 3.400M |
| October 09, 2026 | 3.400M |
| October 08, 2026 | 3.400M |
| October 07, 2026 | 3.400M |
| October 06, 2026 | 3.400M |
| October 05, 2026 | 3.304M |
| October 02, 2026 | 3.304M |
| October 01, 2026 | 3.424M |
| September 30, 2026 | 3.424M |
| September 29, 2026 | 3.418M |
| September 28, 2026 | 3.418M |
| September 25, 2026 | 3.244M |
| September 24, 2026 | 3.244M |
| September 23, 2026 | 3.244M |
| September 22, 2026 | 3.424M |
| September 21, 2026 | 2.922M |
| September 18, 2026 | 2.916M |
| Date | Value |
|---|---|
| September 17, 2026 | 2.880M |
| September 16, 2026 | 2.880M |
| September 15, 2026 | 2.907M |
| September 14, 2026 | 2.920M |
| September 11, 2026 | 3.113M |
| September 10, 2026 | 3.113M |
| September 09, 2026 | 3.304M |
| September 08, 2026 | 3.101M |
| September 04, 2026 | 2.914M |
| September 03, 2026 | 3.006M |
| September 02, 2026 | 2.939M |
| September 01, 2026 | 3.006M |
| August 31, 2026 | 2.932M |
| August 28, 2026 | 3.006M |
| August 27, 2026 | 3.006M |
| August 26, 2026 | 3.006M |
| August 25, 2026 | 3.006M |
| August 24, 2026 | 3.424M |
| August 21, 2026 | 3.424M |
| August 20, 2026 | 3.483M |
| August 19, 2026 | 3.304M |
| August 18, 2026 | 3.597M |
| August 17, 2026 | 3.689M |
| August 14, 2026 | 3.644M |
| August 13, 2026 | 3.961M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.929B |
| Corcept Therapeutics, Inc. | 11.30B |
| Veru, Inc. | 15.94M |
| Johnson & Johnson | 671.59B |
| Eli Lilly & Co. | 1.276T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0152M |
| Total Expenses (Quarterly) | 0.0152M |
| EPS Diluted (Quarterly) | -0.0003 |
| Earnings Yield | -5.27% |
| Normalized Earnings Yield | -4.364 |